'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor
Clinical trial NCT04019873 · COMPLETED
Trial details
- NCT number
- NCT04019873
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-18
- Primary completion
- 2023-04-14
- Enrollment
- 774
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.